These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24853275)

  • 21. Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma.
    Wang D; Lu S; Zhang X; Huang L; Zhao H
    Medicine (Baltimore); 2020 Dec; 99(50):e23369. PubMed ID: 33327261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.
    Nicolini D; Svegliati-Baroni G; Candelari R; Mincarelli C; Mandolesi A; Bearzi I; Mocchegiani F; Vecchi A; Montalti R; Benedetti A; Risaliti A; Vivarelli M
    World J Gastroenterol; 2013 Sep; 19(34):5622-32. PubMed ID: 24039354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated LncRNA TRERNA1 correlated with activation of HIF-1α predicts poor prognosis in hepatocellular carcinoma.
    Qian Y; Li Y; Ge Y; Song W; Fan H
    Pathol Res Pract; 2021 Nov; 227():153612. PubMed ID: 34560417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
    Ding ZN; Dong ZR; Chen ZQ; Yang YF; Yan LJ; Li HC; Liu KX; Yao CY; Yan YC; Yang CC; Li T
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1487-1496. PubMed ID: 33393670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma.
    Lei HW; Huang BR; Cai J; Li CM; Shang CB; Liao ZY; Wan ZD
    Kaohsiung J Med Sci; 2022 Aug; 38(8):781-789. PubMed ID: 35467082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
    Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression.
    Fang X; Zhang D; Zhao W; Gao L; Wang L
    Med Sci Monit; 2020 Aug; 26():e924670. PubMed ID: 32772041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.
    Xu X; Gao D; Yuan X; Liu LI; Zhang X; Liang X; Chen S; Ai M; Chen BO; Shi D; Yang Z; Hoffman RM; Xu J
    Anticancer Res; 2019 Mar; 39(3):1129-1134. PubMed ID: 30842141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
    Wang D; Zhang X; Lu Y; Wang X; Zhu L
    Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy.
    Ye TW; Wang DD; Lu WF; Xie YM; Xu FQ; Fu TW; Zhang KJ; Liu SY; Xie GL; Cheng J; Jiang K; Xiao ZQ; Yao WF; Shen GL; Liu JW; Huang DS; Zhang CW; Liang L
    Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):395-403. PubMed ID: 36939280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression changes of miRNA-203 before and after transcatheter arterial chemoembolization in hepatocellular carcinoma patients and its clinical significance.
    Li X; Li S; Xing X; Wang L
    J BUON; 2021; 26(2):429-434. PubMed ID: 34076989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
    Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
    Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells].
    Xu ZQ; Chen XP; Niu J; Liu EY; Li CH; Peng C
    Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):49-52. PubMed ID: 22490291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
    Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.
    Wang JH; Zhong XP; Zhang YF; Wu XL; Li SH; Jian PE; Ling YH; Shi M; Chen MS; Wei W; Guo RP
    Cell Death Dis; 2017 Sep; 8(9):e3043. PubMed ID: 28880268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.
    Ma W; Shi X; Lu S; Wu L; Wang Y
    Oncol Rep; 2013 Dec; 30(6):2957-62. PubMed ID: 24100543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
    Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.